Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
Nasotracheal intubation with MacGrath videolaryngoscope using Schroeder directional stylet: Case series.

Journal of anaesthesiology, clinical pharmacology

Das B, Ahmed SM, Raza N.
PMID: 25948909
J Anaesthesiol Clin Pharmacol. 2015 Apr-Jun;31(2):239-41. doi: 10.4103/0970-9185.155156.

BACKGROUND AND AIMS: MacGrath videolaryngoscope is one of the recent videolaryngoscopes, which can be used to facilitate nasotracheal intubations using Scroeder directional stylet.MATERIAL AND METHODS: 15 patients, American Society of Anesthesiologists Grades I-II, undergoing tonsillectomy, requiring nasotracheal intubation were...

Cite
Das B, Ahmed SM, Raza N. Nasotracheal intubation with MacGrath videolaryngoscope using Schroeder directional stylet: Case series. J Anaesthesiol Clin Pharmacol. 2015;31(2):239-41doi: 10.4103/0970-9185.155156.
Das, B., Ahmed, S. M., & Raza, N. (2015). Nasotracheal intubation with MacGrath videolaryngoscope using Schroeder directional stylet: Case series. Journal of anaesthesiology, clinical pharmacology, 31(2), 239-41. https://doi.org/10.4103/0970-9185.155156
Das, Bikramjit, et al. "Nasotracheal intubation with MacGrath videolaryngoscope using Schroeder directional stylet: Case series." Journal of anaesthesiology, clinical pharmacology vol. 31,2 (2015): 239-41. doi: https://doi.org/10.4103/0970-9185.155156
Das B, Ahmed SM, Raza N. Nasotracheal intubation with MacGrath videolaryngoscope using Schroeder directional stylet: Case series. J Anaesthesiol Clin Pharmacol. 2015 Apr-Jun;31(2):239-41. doi: 10.4103/0970-9185.155156. PMID: 25948909; PMCID: PMC4411842.
Copy Download .nbib Format: NLM
Targeting γδ T cells for immunotherapy of HIV disease.

Future virology

Pauza CD, Riedel DJ, Gilliam BL, Redfield RR.
PMID: 21339853
Future Virol. 2011 Jan 01;6(1):73-84. doi: 10.2217/FVL.10.78.

Disruption of circulating γδ T-cell populations is an early and common outcome of HIV infection. T-cell receptor (TCR)-γ2δ2 cells (expressing the Vγ2 and Vδ2 chains of the γδ TCR) are depleted, even though they are minimally susceptible to direct...

Cite
Pauza CD, Riedel DJ, Gilliam BL, et al. Targeting γδ T cells for immunotherapy of HIV disease. Future Virol. 2011;6(1):73-84doi: 10.2217/FVL.10.78.
Pauza, C. D., Riedel, D. J., Gilliam, B. L., & Redfield, R. R. (2011). Targeting γδ T cells for immunotherapy of HIV disease. Future virology, 6(1), 73-84. https://doi.org/10.2217/FVL.10.78
Pauza, C David, et al. "Targeting γδ T cells for immunotherapy of HIV disease." Future virology vol. 6,1 (2011): 73-84. doi: https://doi.org/10.2217/FVL.10.78
Pauza CD, Riedel DJ, Gilliam BL, Redfield RR. Targeting γδ T cells for immunotherapy of HIV disease. Future Virol. 2011 Jan 01;6(1):73-84. doi: 10.2217/FVL.10.78. PMID: 21339853; PMCID: PMC3041588.
Copy Download .nbib Format: NLM
H.

Heliyon

Agbe H, Raza N, Dodoo-Arhin D, Chauhan A, Kumar RV.
PMID: 29862361
Heliyon. 2018 Apr 13;4(4):e00599. doi: 10.1016/j.heliyon.2018.e00599. eCollection 2018 Apr.

Ag

Cite
Agbe H, Raza N, Dodoo-Arhin D, et al. H. Heliyon. 2018;4(4):e00599doi: 10.1016/j.heliyon.2018.e00599.
Agbe, H., Raza, N., Dodoo-Arhin, D., Chauhan, A., & Kumar, R. V. (2018). H. Heliyon, 4(4), e00599. https://doi.org/10.1016/j.heliyon.2018.e00599
Agbe, Henry, et al. "H." Heliyon vol. 4,4 (2018): e00599. doi: https://doi.org/10.1016/j.heliyon.2018.e00599
Agbe H, Raza N, Dodoo-Arhin D, Chauhan A, Kumar RV. H. Heliyon. 2018 Apr 13;4(4):e00599. doi: 10.1016/j.heliyon.2018.e00599. eCollection 2018 Apr. PMID: 29862361; PMCID: PMC5968178.
Copy Download .nbib Format: NLM
A comparative study of McGrath and Airtraq videolaryngoscopes for tracheal intubation.

Journal of anaesthesiology, clinical pharmacology

Raza N, Hasan M, Ahmed SM, Bano S, Athar M.
PMID: 28781449
J Anaesthesiol Clin Pharmacol. 2017 Apr-Jun;33(2):221-225. doi: 10.4103/joacp.JOACP_370_15.

BACKGROUND AND AIMS: Many cases of difficult tracheal intubation remain unrecognized until after induction of anesthesia. McGrath and Airtraq videolaryngoscopes are among the novel laryngoscopes that have an advantage over the conventional laryngoscopes in case of unanticipated difficult airway....

Cite
Raza N, Hasan M, Ahmed SM, et al. A comparative study of McGrath and Airtraq videolaryngoscopes for tracheal intubation. J Anaesthesiol Clin Pharmacol. 2017;33(2):221-225doi: 10.4103/joacp.JOACP_370_15.
Raza, N., Hasan, M., Ahmed, S. M., Bano, S., & Athar, M. (2017). A comparative study of McGrath and Airtraq videolaryngoscopes for tracheal intubation. Journal of anaesthesiology, clinical pharmacology, 33(2), 221-225. https://doi.org/10.4103/joacp.JOACP_370_15
Raza, Nadeem, et al. "A comparative study of McGrath and Airtraq videolaryngoscopes for tracheal intubation." Journal of anaesthesiology, clinical pharmacology vol. 33,2 (2017): 221-225. doi: https://doi.org/10.4103/joacp.JOACP_370_15
Raza N, Hasan M, Ahmed SM, Bano S, Athar M. A comparative study of McGrath and Airtraq videolaryngoscopes for tracheal intubation. J Anaesthesiol Clin Pharmacol. 2017 Apr-Jun;33(2):221-225. doi: 10.4103/joacp.JOACP_370_15. PMID: 28781449; PMCID: PMC5520596.
Copy Download .nbib Format: NLM
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.

Frontiers in immunology

Pauza CD, Liou ML, Lahusen T, Xiao L, Lapidus RG, Cairo C, Li H.
PMID: 29937769
Front Immunol. 2018 Jun 08;9:1305. doi: 10.3389/fimmu.2018.01305. eCollection 2018.

Human gamma delta T cells have extraordinary properties including the capacity for tumor cell killing. The major gamma delta T cell subset in human beings is designated Vγ9Vδ2 and is activated by intermediates of isoprenoid biosynthesis or aminobisphosphonate inhibitors...

Cite
Pauza CD, Liou ML, Lahusen T, et al. Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. Front Immunol. 2018;9:1305doi: 10.3389/fimmu.2018.01305.
Pauza, C. D., Liou, M. L., Lahusen, T., Xiao, L., Lapidus, R. G., Cairo, C., & Li, H. (2018). Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. Frontiers in immunology, 91305. https://doi.org/10.3389/fimmu.2018.01305
Pauza, C David, et al. "Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local." Frontiers in immunology vol. 9 (2018): 1305. doi: https://doi.org/10.3389/fimmu.2018.01305
Pauza CD, Liou ML, Lahusen T, Xiao L, Lapidus RG, Cairo C, Li H. Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local. Front Immunol. 2018 Jun 08;9:1305. doi: 10.3389/fimmu.2018.01305. eCollection 2018. PMID: 29937769; PMCID: PMC6003257.
Copy Download .nbib Format: NLM
The photocatalytic performance and structural characteristics of nickel cobalt ferrite nanocomposites after doping with bismuth.

Journal of colloid and interface science

Abbas N, Rubab N, Kim KH, Chaudhry R, Manzoor S, Raza N, Tariq M, Lee J, Manzoor S.
PMID: 33794411
J Colloid Interface Sci. 2021 Jul 15;594:902-913. doi: 10.1016/j.jcis.2021.03.094. Epub 2021 Mar 19.

Here, a novel bismuth-doped nickel-cobalt ferrite (Ni

Cite
Abbas N, Rubab N, Kim KH, et al. The photocatalytic performance and structural characteristics of nickel cobalt ferrite nanocomposites after doping with bismuth. J Colloid Interface Sci. 2021;594:902-913doi: 10.1016/j.jcis.2021.03.094.
Abbas, N., Rubab, N., Kim, K. H., Chaudhry, R., Manzoor, S., Raza, N., Tariq, M., Lee, J., & Manzoor, S. (2021). The photocatalytic performance and structural characteristics of nickel cobalt ferrite nanocomposites after doping with bismuth. Journal of colloid and interface science, 594902-913. https://doi.org/10.1016/j.jcis.2021.03.094
Abbas, Naseem, et al. "The photocatalytic performance and structural characteristics of nickel cobalt ferrite nanocomposites after doping with bismuth." Journal of colloid and interface science vol. 594 (2021): 902-913. doi: https://doi.org/10.1016/j.jcis.2021.03.094
Abbas N, Rubab N, Kim KH, Chaudhry R, Manzoor S, Raza N, Tariq M, Lee J, Manzoor S. The photocatalytic performance and structural characteristics of nickel cobalt ferrite nanocomposites after doping with bismuth. J Colloid Interface Sci. 2021 Jul 15;594:902-913. doi: 10.1016/j.jcis.2021.03.094. Epub 2021 Mar 19. PMID: 33794411.
Copy Download .nbib Format: NLM
Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma.

Applied immunohistochemistry & molecular morphology : AIMM

Schlaepfer Sales CB, Guimarães VSN, Valverde LF, Dias RB, Freitas RD, Siquara da Rocha LO, Coelho de Miranda M, Vilas Bôas DS, Gonçalves Agra IM, Dos Santos JN, Gurgel Rocha CA.
PMID: 33512817
Appl Immunohistochem Mol Morphol. 2021 May-Jun 01;29(5):345-351. doi: 10.1097/PAI.0000000000000907.

Proteoglycans are involved in tumor development and may regulate the Hedgehog (HH) pathway. This study aimed to investigate the gene and protein expression of glypican-1 (GPC1), -3 (GPC3), and -5 (GPC5) in oral squamous cell carcinoma (OSCC) and tumor-free...

Cite
Schlaepfer Sales CB, Guimarães VSN, Valverde LF, et al. Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol. 2021;29(5):345-351doi: 10.1097/PAI.0000000000000907.
Schlaepfer Sales, C. B., Guimarães, V. S. N., Valverde, L. F., Dias, R. B., Freitas, R. D., Siquara da Rocha, L. O., Coelho de Miranda, M., Vilas Bôas, D. S., Gonçalves Agra, I. M., Dos Santos, J. N., & Gurgel Rocha, C. A. (2021). Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma. Applied immunohistochemistry & molecular morphology : AIMM, 29(5), 345-351. https://doi.org/10.1097/PAI.0000000000000907
Schlaepfer Sales, Caroline B, et al. "Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma." Applied immunohistochemistry & molecular morphology : AIMM vol. 29,5 (2021): 345-351. doi: https://doi.org/10.1097/PAI.0000000000000907
Schlaepfer Sales CB, Guimarães VSN, Valverde LF, Dias RB, Freitas RD, Siquara da Rocha LO, Coelho de Miranda M, Vilas Bôas DS, Gonçalves Agra IM, Dos Santos JN, Gurgel Rocha CA. Glypican-1, -3, -5 (GPC1, GPC3, GPC5) and Hedgehog Pathway Expression in Oral Squamous Cell Carcinoma. Appl Immunohistochem Mol Morphol. 2021 May-Jun 01;29(5):345-351. doi: 10.1097/PAI.0000000000000907. PMID: 33512817.
Copy Download .nbib Format: NLM
Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS.

Multiple sclerosis international

Edwards EM, Kegelmeyer DA, Kloos AD, Nitta M, Raza D, Nichols-Larsen DS, Fritz NE.
PMID: 32963832
Mult Scler Int. 2020 Sep 08;2020:6707414. doi: 10.1155/2020/6707414. eCollection 2020.

BACKGROUND: Individuals with multiple sclerosis (MS) experience deficits in motor and cognitive domains, resulting in impairment in dual-task walking ability. The goal of this study was to compare performance of forward walking and backward walking in single- and dual-task...

Cite
Edwards EM, Kegelmeyer DA, Kloos AD, et al. Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS. Mult Scler Int. 2020;2020:6707414doi: 10.1155/2020/6707414.
Edwards, E. M., Kegelmeyer, D. A., Kloos, A. D., Nitta, M., Raza, D., Nichols-Larsen, D. S., & Fritz, N. E. (2020). Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS. Multiple sclerosis international, 20206707414. https://doi.org/10.1155/2020/6707414
Edwards, Erin M, et al. "Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS." Multiple sclerosis international vol. 2020 (2020): 6707414. doi: https://doi.org/10.1155/2020/6707414
Edwards EM, Kegelmeyer DA, Kloos AD, Nitta M, Raza D, Nichols-Larsen DS, Fritz NE. Backward Walking and Dual-Task Assessment Improve Identification of Gait Impairments and Fall Risk in Individuals with MS. Mult Scler Int. 2020 Sep 08;2020:6707414. doi: 10.1155/2020/6707414. eCollection 2020. PMID: 32963832; PMCID: PMC7495208.
Copy Download .nbib Format: NLM
A Fatal Case of Primary Orbital Ewing's Sarcoma with Intracranial Extensions in a Six-year-old Girl.

Cureus

Raza N, Iqbal Z, Nasim M, Nasir S, Sehar A.
PMID: 31890444
Cureus. 2019 Nov 27;11(11):e6248. doi: 10.7759/cureus.6248.

Ewing's sarcoma (ES) is the second most common skeletal tumor seen in children and adolescents which typically involves the long bones and the axial skeleton. ES involving the orbits is extremely rare and can lead to serious consequences. Patients...

Cite
Raza N, Iqbal Z, Nasim M, et al. A Fatal Case of Primary Orbital Ewing's Sarcoma with Intracranial Extensions in a Six-year-old Girl. Cureus. 2019;11(11):e6248doi: 10.7759/cureus.6248.
Raza, N., Iqbal, Z., Nasim, M., Nasir, S., & Sehar, A. (2019). A Fatal Case of Primary Orbital Ewing's Sarcoma with Intracranial Extensions in a Six-year-old Girl. Cureus, 11(11), e6248. https://doi.org/10.7759/cureus.6248
Raza, Natasha, et al. "A Fatal Case of Primary Orbital Ewing's Sarcoma with Intracranial Extensions in a Six-year-old Girl." Cureus vol. 11,11 (2019): e6248. doi: https://doi.org/10.7759/cureus.6248
Raza N, Iqbal Z, Nasim M, Nasir S, Sehar A. A Fatal Case of Primary Orbital Ewing's Sarcoma with Intracranial Extensions in a Six-year-old Girl. Cureus. 2019 Nov 27;11(11):e6248. doi: 10.7759/cureus.6248. PMID: 31890444; PMCID: PMC6935333.
Copy Download .nbib Format: NLM
Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: An .

Veterinary world

Hendrawan S, Kusnadi Y, Lagonda CA, Fauza D, Lheman J, Budi E, Manurung BS, Baer HU, Tansil Tan S.
PMID: 34566328
Vet World. 2021 Aug;14(8):2109-2117. doi: 10.14202/vetworld.2021.2109-2117. Epub 2021 Aug 17.

BACKGROUND AND AIM: Human umbilical cord mesenchymal stem cells (hUC-MSCs) and its conditioned medium (CM) promote wound healing. This study investigated the wound healing potential of hUC-MSC CM MATERIALS AND METHODS: The CM from hUC-MSC CM prepared under hypoxic...

Cite
Hendrawan S, Kusnadi Y, Lagonda CA, et al. Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: An . Vet World. 2021;14(8):2109-2117doi: 10.14202/vetworld.2021.2109-2117.
Hendrawan, S., Kusnadi, Y., Lagonda, C. A., Fauza, D., Lheman, J., Budi, E., Manurung, B. S., Baer, H. U., & Tansil Tan, S. (2021). Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: An . Veterinary world, 14(8), 2109-2117. https://doi.org/10.14202/vetworld.2021.2109-2117
Hendrawan, Siufui, et al. "Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: An ." Veterinary world vol. 14,8 (2021): 2109-2117. doi: https://doi.org/10.14202/vetworld.2021.2109-2117
Hendrawan S, Kusnadi Y, Lagonda CA, Fauza D, Lheman J, Budi E, Manurung BS, Baer HU, Tansil Tan S. Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: An . Vet World. 2021 Aug;14(8):2109-2117. doi: 10.14202/vetworld.2021.2109-2117. Epub 2021 Aug 17. PMID: 34566328; PMCID: PMC8448625.
Copy Download .nbib Format: NLM
Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure.

Molecular therapy. Methods & clinical development

Li H, Lahusen T, Xiao L, Muvarak N, Blazkova J, Chun TW, Pauza CD.
PMID: 32462053
Mol Ther Methods Clin Dev. 2020 May 03;17:1048-1060. doi: 10.1016/j.omtm.2020.04.024. eCollection 2020 Jun 12.

Activation, infection, and eventual depletion of human immunodeficiency virus (HIV)-specific cluster of differentiation 4 (CD4) T cells are the crucial pathogenetic events in acquired immunodeficiency syndrome (AIDS). We developed a cell and gene therapy to reconstitute HIV-specific CD4 T...

Cite
Li H, Lahusen T, Xiao L, et al. Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure. Mol Ther Methods Clin Dev. 2020;17:1048-1060doi: 10.1016/j.omtm.2020.04.024.
Li, H., Lahusen, T., Xiao, L., Muvarak, N., Blazkova, J., Chun, T. W., & Pauza, C. D. (2020). Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure. Molecular therapy. Methods & clinical development, 171048-1060. https://doi.org/10.1016/j.omtm.2020.04.024
Li, Haishan, et al. "Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure." Molecular therapy. Methods & clinical development vol. 17 (2020): 1048-1060. doi: https://doi.org/10.1016/j.omtm.2020.04.024
Li H, Lahusen T, Xiao L, Muvarak N, Blazkova J, Chun TW, Pauza CD. Preclinical Development and Clinical-Scale Manufacturing of HIV Gag-Specific, LentivirusModified CD4 T Cells for HIV Functional Cure. Mol Ther Methods Clin Dev. 2020 May 03;17:1048-1060. doi: 10.1016/j.omtm.2020.04.024. eCollection 2020 Jun 12. PMID: 32462053; PMCID: PMC7240062.
Copy Download .nbib Format: NLM
Predictors of type IIIa endoleak after Endovascular Aortic Repair with anatomic fixation endografts.

Journal of vascular surgery

Castelli MA, Pfund G, Auza D, Battú C, Balestrini J, De Luca I, Zaefferer P.
PMID: 34788651
J Vasc Surg. 2021 Nov 14; doi: 10.1016/j.jvs.2021.10.054. Epub 2021 Nov 14.

OBJECTIVE: Concern regarding the use of anatomic fixation endografts was raised as previous data suggested increased risk of late device uncoupling and type IIIa endoleak in this setting. Some risk factors have been identified as predictors of graft failure....

Cite
Castelli MA, Pfund G, Auza D, et al. Predictors of type IIIa endoleak after Endovascular Aortic Repair with anatomic fixation endografts. J Vasc Surg. 2021;doi: 10.1016/j.jvs.2021.10.054.
Castelli, M. A., Pfund, G., Auza, D., Battú, C., Balestrini, J., De Luca, I., & Zaefferer, P. (2021). Predictors of type IIIa endoleak after Endovascular Aortic Repair with anatomic fixation endografts. Journal of vascular surgery, . https://doi.org/10.1016/j.jvs.2021.10.054
Castelli, Mariano A, et al. "Predictors of type IIIa endoleak after Endovascular Aortic Repair with anatomic fixation endografts." Journal of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jvs.2021.10.054
Castelli MA, Pfund G, Auza D, Battú C, Balestrini J, De Luca I, Zaefferer P. Predictors of type IIIa endoleak after Endovascular Aortic Repair with anatomic fixation endografts. J Vasc Surg. 2021 Nov 14; doi: 10.1016/j.jvs.2021.10.054. Epub 2021 Nov 14. PMID: 34788651.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries